» Articles » PMID: 15651040

Structure and Biosynthesis of Myxochromides S1-3 in Stigmatella Aurantiaca: Evidence for an Iterative Bacterial Type I Polyketide Synthase and for Module Skipping in Nonribosomal Peptide Biosynthesis

Overview
Journal Chembiochem
Specialty Biochemistry
Date 2005 Jan 15
PMID 15651040
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

The myxobacterium Stigmatella aurantiaca DW4/3-1 harbours an astonishing variety of secondary metabolic gene clusters, at least two of which were found by gene inactivation experiments to be connected to the biosynthesis of previously unknown metabolites. In this study, we elucidate the structures of myxochromides S1-3, novel cyclic pentapeptide natural products possessing unsaturated polyketide side chains, and identify the corresponding biosynthetic gene locus, made up of six nonribosomal peptide synthetase modules. By analyzing the deduced substrate specificities of the adenylation domains, it is shown that module 4 is most probably skipped during the biosynthetic process. The polyketide synthase MchA harbours only one module and is presumably responsible for the formation of the variable complete polyketide side chains. These data indicate that MchA is responsible for an unusual iterative polyketide chain assembly.

Citing Articles

Identification by Synthesis: Imidacins, Urocanate-Derived Alkaloids from the Myxobacterium .

Kostka M, Krug D, Herrmann J, Dickschat J, Meyer J, Muller R Org Lett. 2024; 26(30):6359-6363.

PMID: 39037587 PMC: 11301661. DOI: 10.1021/acs.orglett.4c02036.


Antibiotic Skeletal Diversification via Differential Enoylreductase Recruitment and Module Iteration in -Acyltransferase Polyketide Synthases.

Jian X, Pang F, Hobson C, Jenner M, Alkhalaf L, Challis G J Am Chem Soc. 2024; 146(9):6114-6124.

PMID: 38389455 PMC: 10921412. DOI: 10.1021/jacs.3c13667.


Biosynthesis of Antifungal Solanimycin May Involve an Iterative Nonribosomal Peptide Synthetase Module.

Murphy A, Corney M, Monson R, Matilla M, Salmond G, Leeper F ACS Chem Biol. 2023; 18(5):1148-1157.

PMID: 37068480 PMC: 10204066. DOI: 10.1021/acschembio.2c00947.


Myxobacteria as a Source of New Bioactive Compounds: A Perspective Study.

Bhat M, Mishra A, Bhat M, Banday M, Bashir O, Rather I Pharmaceutics. 2021; 13(8).

PMID: 34452226 PMC: 8401837. DOI: 10.3390/pharmaceutics13081265.


Integrating genomics and metabolomics for scalable non-ribosomal peptide discovery.

Behsaz B, Bode E, Gurevich A, Shi Y, Grundmann F, Acharya D Nat Commun. 2021; 12(1):3225.

PMID: 34050176 PMC: 8163882. DOI: 10.1038/s41467-021-23502-4.